Taipei mayoral election campaigns have been clouded by issues concerning Taiwan’s COVID-19 response and vaccine procurement over the past two years.
As Democratic Progressive Party (DPP) Taipei mayoral candidate Chen Shih-chung (陳時中) was head of the Central Epidemic Command Center (CECC) for more than 900 days during the COVID-19 pandemic, his political opponents have been attacking him for what they called “poor COVID-19 responses.”
The Chinese Nationalist Party’s (KMT) Legislator and Taipei mayoral candidate Chiang Wan-an (蔣萬安) and independent Taipei mayoral candidate Vivian Huang (黃珊珊), a former Taipei deputy mayor, have aggressively and negatively campaigned against Chen.
Since Chen announced his bid for mayor in July, he has been called a “runaway CECC head,” criticized for cutting quarantine time and causing local COVID-19 outbreaks, branded incapable of securing enough vaccines last year, and accused of blocking vaccine purchases, concealing vaccine prices and wasting taxpayer money by disposing of expired vaccines.
Huang said that Chen was “murdering for money,” as she claimed the government had blocked the purchase of imported vaccines to profit from Taiwan’s homegrown Medigen COVID-19 vaccine.
Chiang also said Chen showed “disregard for human lives” and “had no empathy for the victims’ families,” while the KMT legislative caucus last week filed a complaint against him for alleged dereliction of duty in purchasing COVID-19 vaccines.
When the local outbreak of the Omicron variant of SARS-CoV-2 began in April, the KMT consistently called for Chen to step down as CECC head due to his “poor COVID-19 response,” but it criticized him for “running away” when he resigned in July after the infections stabilized. Daily local caseloads dropped to about 20,000 from the peak of about 90,000, while antiviral drug prescriptions and COVID-19 hospital bed vacancy rates were high.
The KMT legislative caucus in July 2020 urged the government to allocate more funding for domestic COVID-19 vaccine development and ease clinical trial requirements due to fears that the nation would not gain access to vaccine supplies as fast as other countries. After the government purchased vaccines, the KMT later labeled the AstraZeneca vaccine “unwanted” and dangerous, saying it could cause blood clots. It called receivers of the Medigen vaccine “lab rats,” demanded a greater supply of the Pfizer-BioNTech vaccine and questioned whether vaccines had been purchased at inflated prices.
The KMT’s demands — buying vaccines before other countries at low cost, providing vaccine brand variety, revealing non-disclosure agreements, not wasting taxpayers’ money by purchasing too many doses, while also funding research for domestically made vaccines — are basically impossible.
In January last year, Israel was ahead of many bigger countries in COVID-19 vaccination rates. It paid a premium to get early Pfizer-BioNTech vaccines, agreeing to provide the vaccine company with efficacy data among those vaccinated. Although its contract with Pfizer was made public shortly after it was signed, the specifics around the cost were redacted.
Pfizer-BioNTech had stated that it uses “a tiered pricing formula based on volume and delivery dates,” and the CECC has clarified that a non-disclosure agreement was signed with the vaccine manufacturers, yet the KMT continues to obscure the facts.
While many countries have reported destroying millions of expired COVID-19 vaccines, including the US, which discarded 82.1 million doses from December 2020 to mid-May, the KMT continues to attack Chen for the disposal of Taiwan’s expired vaccines.
Negative campaigning focused on previous COVID-19 policies does not improve the well-being of Taipei residents. Debates on policies for better municipal governance would be more constructive.
When it became clear that the world was entering a new era with a radical change in the US’ global stance in US President Donald Trump’s second term, many in Taiwan were concerned about what this meant for the nation’s defense against China. Instability and disruption are dangerous. Chaos introduces unknowns. There was a sense that the Chinese Nationalist Party (KMT) might have a point with its tendency not to trust the US. The world order is certainly changing, but concerns about the implications for Taiwan of this disruption left many blind to how the same forces might also weaken
As the new year dawns, Taiwan faces a range of external uncertainties that could impact the safety and prosperity of its people and reverberate in its politics. Here are a few key questions that could spill over into Taiwan in the year ahead. WILL THE AI BUBBLE POP? The global AI boom supported Taiwan’s significant economic expansion in 2025. Taiwan’s economy grew over 7 percent and set records for exports, imports, and trade surplus. There is a brewing debate among investors about whether the AI boom will carry forward into 2026. Skeptics warn that AI-led global equity markets are overvalued and overleveraged
Japanese Prime Minister Sanae Takaichi on Monday announced that she would dissolve parliament on Friday. Although the snap election on Feb. 8 might appear to be a domestic affair, it would have real implications for Taiwan and regional security. Whether the Takaichi-led coalition can advance a stronger security policy lies in not just gaining enough seats in parliament to pass legislation, but also in a public mandate to push forward reforms to upgrade the Japanese military. As one of Taiwan’s closest neighbors, a boost in Japan’s defense capabilities would serve as a strong deterrent to China in acting unilaterally in the
Taiwan last week finally reached a trade agreement with the US, reducing tariffs on Taiwanese goods to 15 percent, without stacking them on existing levies, from the 20 percent rate announced by US President Donald Trump’s administration in August last year. Taiwan also became the first country to secure most-favored-nation treatment for semiconductor and related suppliers under Section 232 of the US Trade Expansion Act. In return, Taiwanese chipmakers, electronics manufacturing service providers and other technology companies would invest US$250 billion in the US, while the government would provide credit guarantees of up to US$250 billion to support Taiwanese firms
RSS